John Pippen

Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer

Journal of Clinical Oncology · 2009 · 787 citations

Iniparib plus chemotherapy in metastatic triple-negative breast cancer

New England Journal of Medicine · 2011 · 635 citations